Menu Back toSession 6 : Development of Innovative Drug

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Session 6 : Development of Innovative Drug

Session Chair(s)

Heesung  Kim

Heesung Kim

  • Director
  • NIFDS, Korea, Republic of


Jun  Park, PhD

Jun Park, PhD

  • EVP/Chief Technology Officer
  • ILIAS Biologics, Inc., Korea, Republic of
Hae-Young  Ahn, PhD

Hae-Young Ahn, PhD

  • President
  • Ahn Bio, United States
Youngju  Choi

Youngju Choi

  • Director NIFDS
  • Ministry of Food and Drug Safety, Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email